Selank: A Scientific Perspective on Its Effects and Mechanism of Action

Selank is a synthetic heptapeptide, meaning a peptide composed of seven amino acid residues. It is derived from the naturally occurring human peptide tuftsin and was developed primarily for research into its potential effects on the nervous and immune systems.

Selank has attracted the greatest attention in connection with research into anxiety, GABAergic signaling, serotonin metabolism, learning, and memory. Small clinical studies have also investigated Selank in people with generalized anxiety disorder and neurasthenia, while much of the knowledge about its molecular mechanisms comes from cellular and animal studies.

Therefore, when evaluating Selank, it is important to distinguish between what has been observed in humans and what currently remains a preclinical research hypothesis.

What Is Selank?

Selank is a synthetic peptide with the following sequence:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

It therefore consists of seven amino acid residues. Its molecular weight is approximately 751.9 g/mol.

The core of its structure is derived from the naturally occurring tetrapeptide tuftsin, which has the sequence Thr-Lys-Pro-Arg.

In Selank, three additional amino acid residues - Pro-Gly-Pro - were added to this sequence. In experimental research, this modification has been associated, among other things, with increased metabolic stability of the peptide.

Selank was developed in Russia and appears in the scientific literature primarily in connection with research into:

• anxiety and the stress response,
• the GABAergic system,
• serotonin,
• learning and memory,
• neurotrophic mechanisms,
• enkephalins,
• gene expression,
• cytokines and immunomodulation.

However, this does not mean that all of these effects have been equally well confirmed in humans.

How Does Selank Work?

There is probably no single receptor or mechanism that can explain all of the biological effects observed with Selank.

Research suggests that it may influence several systems simultaneously.

Scientists have focused primarily on:

the GABAergic system, serotonin and dopamine signaling, enkephalins, neurotrophic factors, and regulation of gene expression.

Let us examine these individual mechanisms in more detail.

How Is Selank Related to the GABAergic System?

One of the most interesting areas of Selank research is its relationship with the GABAergic system.

GABA, or gamma-aminobutyric acid, is one of the principal inhibitory neurotransmitters in the central nervous system.

In simple terms, it helps regulate neuronal activity and prevents excessive neuronal “excitation.”

The GABAergic system is also an important target of conventional benzodiazepines used in anxiety disorders.

What Has Selank Research Shown?

In a study in rats, researchers analyzed gene expression in the frontal cortex following administration of Selank or GABA.

During the first hour, changes in the expression of dozens of genes associated with neurotransmission were recorded.

The affected genes included those associated with:

• GABA receptors,
• neurotransmitter transport,
• ion channels,
• dopamine signaling,
• serotonin signaling.

The authors identified a positive correlation between some of the changes induced by Selank and GABA and proposed that one possible mechanism of Selank may involve allosteric modulation of the GABAergic system.

However, this does not mean that Selank works in the same way as benzodiazepines.

Is Selank Similar to Benzodiazepines?

Some experimental studies have observed similarities between the behavioral effects of Selank and benzodiazepines such as diazepam.

However, the mechanisms are not identical.

Benzodiazepines bind directly to a specific site on the GABA-A receptor and enhance the effects of GABA.

With Selank, research instead focuses on indirect modulation of the GABAergic system and gene expression.

From a research perspective, this distinction is particularly interesting because it may help explain why some experimental studies have observed an anxiolytic profile without the same type of hypnosedative effects typically associated with conventional benzodiazepines.

However, large modern clinical studies are still lacking to confirm the clinical significance of this difference.

Selank and Anxiety: Are There Human Studies?

Yes.

Anxiety disorders are among the areas of Selank research for which some human data are available.

One published study included 62 patients with generalized anxiety disorder and neurasthenia.

Thirty patients received Selank and 32 patients received medazepam, which belongs to the benzodiazepine class.

The patients’ condition was evaluated using psychometric scales including the Hamilton scale, Zung scale, and Clinical Global Impression scale.

The authors reported a comparable anxiolytic effect in both groups, while anti-asthenic and psychostimulant properties were also observed with Selank.

Does This Mean Selank Is a Confirmed Alternative to Benzodiazepines?

No.

This was a relatively small study, and the evidence base is considerably smaller than that available for standard medications used to treat anxiety disorders.

The result is therefore interesting for further research, but it is not sufficient to conclude that Selank represents a clinically established substitute for benzodiazepines.

Selank, Stress, and Diazepam

Additional research examined Selank together with diazepam in a model of chronic unpredictable mild stress in rats.

Researchers evaluated animal behavior and anxiety-like manifestations.

The experiment showed that Selank influenced the behavioral response to chronic stress, and additional changes in the anxiolytic profile were observed when it was combined with diazepam.

However, it is again important to emphasize that:

this was an animal experiment, not a clinical comparison of Selank and diazepam combination therapy in humans.

Enkephalins as Another Investigated Mechanism

Another highly interesting area of Selank research involves enkephalins.

Enkephalins are naturally occurring regulatory peptides belonging to the group of endogenous opioid peptides.

Among other functions, they participate in:

• pain regulation,
• the stress response,
• emotional processes,
• opioid receptor activity.

However, they do not remain in the body indefinitely. They are broken down by specific enzymes known as enkephalin-degrading enzymes or enkephalinases.

How May Selank Affect Enkephalin Breakdown?

Laboratory experiments using human serum have shown that Selank can inhibit enzymes involved in the degradation of enkephalins.

Researchers have also investigated this mechanism in connection with anxiety disorders.

In one study, the activity of enkephalin-degrading enzymes was compared in patients with various anxiety and phobic disorders.

The findings supported the hypothesis that enkephalin metabolism may represent one mechanism relevant to certain forms of anxiety and potentially one of the targets of Selank’s biological effects.

Additional support for this mechanism has come from experiments in different strains of mice, in which the anxiolytic activity of Selank was associated with changes in the activity of enkephalin-degrading enzymes.

Selank, Serotonin, and the Brain

Another neurotransmitter frequently discussed in Selank research is serotonin - 5-hydroxytryptamine or 5-HT.

Serotonin is an important neurotransmitter involved in numerous processes, including mood regulation, sleep, stress responses, and certain cognitive functions.

Research in rats has shown that Selank may influence serotonin metabolism in specific regions of the brain.

In one experimental study, a single administration of Selank was followed by activation of 5-HT metabolism in the hypothalamus and caudal brainstem over a period of approximately 30 minutes to two hours.

Another experiment in rats with pharmacologically suppressed serotonin synthesis also demonstrated changes in 5-HT metabolism after Selank administration.

These findings support the hypothesis that the serotonergic system may form part of Selank’s complex mechanism of action.

However, it is currently not possible to simply state that Selank “increases serotonin” in humans. Such a claim would be overly simplistic.

Selank, Learning, and Memory

Alongside anxiety, another major area of research is memory and learning.

In an experiment involving rats, researchers examined the process of memory consolidation - the phase during which newly acquired information gradually becomes a more stable memory trace.

After Selank administration during the consolidation phase, retention was tested:

• after 24 hours,
• after 7 days,
• after 30 days.

The results showed increased stability of the memory trace throughout the 30-day observation period.

The researchers therefore proposed that Selank may influence mechanisms of memory storage under experimental conditions.

Does Selank Improve Memory in Healthy Humans?

Based on the available evidence, this cannot be reliably stated.

A substantial proportion of the data on cognitive effects comes from animal models.

It is therefore more appropriate to refer to research into learning and memory mechanisms rather than describing Selank as a clinically confirmed “memory enhancer.”

BDNF and Neuroplasticity

In the context of neuroplasticity, BDNF - brain-derived neurotrophic factor - is also frequently discussed.

BDNF is one of the molecules important for neuronal survival, synaptic plasticity, and processes associated with learning and memory.

Experimental data from rats suggest that intranasally administered Selank may influence BDNF expression in the hippocampus.

In another animal model investigating memory impairment associated with ethanol exposure, Selank affected both cognitive outcomes and changes in BDNF levels in the hippocampus and frontal cortex.

However, these results do not mean that Selank has been proven to increase BDNF or neuroplasticity in humans.

What Does Selank Have to Do with the Immune System?

This area of research is related to Selank’s origin.

Selank is derived from tuftsin, a naturally occurring peptide associated with regulation of certain immune system functions.

Researchers have therefore investigated whether the synthetic analogue retains some immunomodulatory properties.

The findings suggest that it may - at least under certain experimental conditions.

IL-6 and Regulation of Immune Signaling

One molecule that has been investigated is interleukin-6 (IL-6).

IL-6 is a cytokine, meaning a signaling molecule used by the immune system. Its function is complex and, depending on the biological context, may be associated with both pro-inflammatory and regulatory processes.

In a laboratory study examining peripheral blood cells, Selank was associated with changes in IL-6 expression.

The results were not straightforward: in cells from patients with depression, IL-6 gene expression was suppressed at a particular concentration, while under certain conditions the IL-6 concentration in the cell culture increased.

This is a good example of why it is inappropriate to simplify this research into the statement:

“Selank reduces inflammation.”

Immune signaling is considerably more complex.

Regulation of Inflammation-Related Genes

Research in mice has shown that Selank may influence the expression of several genes involved in inflammatory and immune processes.

One of the more prominently affected genes was Bcl6, which plays an important role in the development and regulation of immune cells.

Another study examined the temporal dynamics of genes associated with the immune response and identified changes following administration of both Selank and its shorter fragments.

These findings therefore support describing Selank as an immunomodulatory research peptide of scientific interest, but not as a clinically proven means of “boosting immunity.”

Cytokines and Chronic Stress

The connection between the nervous and immune systems is an important area of modern neurobiology.

Chronic stress does not affect only the brain. It can also alter immune and inflammatory signaling pathways.

In one experimental model of social stress in animals, Selank affected concentrations of cytokines including:

• IL-1β,
• IL-6,
• TNF-α,
• TGF-β1.

These findings support further research into the relationship between Selank, the stress response, and immune signaling.

However, this was again a preclinical experiment.

What Is the Difference Between Selank and Semax?

Selank and Semax are very often confused.

Both are synthetic peptides developed and investigated in Russia, and both appear in research involving the central nervous system.

However, their origins and structures are different.

Selank

Selank is derived from tuftsin and has the sequence:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Research focuses strongly on:

• anxiolytic mechanisms,
• GABA,
• serotonin,
• enkephalins,
• memory,
• immunomodulation.

Semax

Semax, by contrast, is a peptide derived from the ACTH(4–10) fragment.

A major area of Semax research involves neurotrophic, neuroprotective, and cognitive mechanisms.

It is therefore scientifically incorrect to automatically extrapolate findings from Semax studies to Selank.

If you’re interested in learning more about Semax and the areas being investigated in research, read our article - Semax: A Scientific Perspective on a Neuropeptide in the Context of Contemporary Research.

What Does Selank Research Actually Show?

For Selank, it is useful to divide the evidence into two groups.

What Has Been Studied in Humans?

Smaller human studies have investigated Selank primarily in patients with:

• generalized anxiety disorder,
• neurasthenia,
• certain anxiety and phobic disorders.

One study involving 62 patients compared Selank with medazepam and reported anxiolytic outcomes in both groups.

Human samples have also been used in research into:

• enkephalin-degrading enzymes,
• IL-6,
• immunomodulatory mechanisms.

These data are scientifically interesting, but the overall clinical evidence base remains limited.

What Comes Predominantly from Animal or Cellular Research?

Preclinical studies investigate:

• GABAergic signaling,
• serotonin metabolism,
• gene expression in the brain,
• memory consolidation,
• BDNF,
• responses to chronic stress,
• cytokines,
• regulation of inflammatory genes.

This distinction is essential when interpreting information about Selank.

What Do We Still Not Know?

Although mechanistic research into Selank is extensive and interesting, significant gaps in knowledge remain.

In particular, large, modern, independent, and well-controlled clinical studies are lacking to precisely define its efficacy and safety profile for specific indications.

Based on the current evidence, it is therefore not scientifically appropriate to claim that Selank has been proven in humans to:

• treat generalized anxiety disorder,
• replace benzodiazepines,
• treat depression,
• improve memory in healthy individuals,
• increase BDNF,
• strengthen immunity,
• treat inflammatory diseases,
• protect the brain from damage.

For most of these areas, there are preclinical signals or smaller research studies, rather than sufficient clinical evidence.

Why Is Selank Interesting for Research?

Selank is unusual primarily because its research involves both the nervous and immune systems.

Rather than having one simple target, it is being investigated across a range of mechanisms.

1. GABAergic Signaling

Selank may alter the expression of genes associated with GABA receptors and other components of neurotransmission.

2. Serotonin System

Experimental findings suggest changes in serotonin metabolism in certain regions of the brain.

3. Enkephalins

Selank inhibited enkephalin-degrading enzymes in human serum, representing another possible mechanism of its biological activity.

4. Memory and Neuroplasticity

Animal models investigate its effects on memory consolidation and neurotrophic mechanisms, including BDNF.

5. Immune Signaling

Research has demonstrated changes in the expression of cytokines and genes involved in the regulation of immune and inflammatory processes.

It is this combination of research areas that makes Selank an interesting experimental tool for neurobiological and immunological research.

Frequently Asked Questions About Selank

What Is Selank?

Selank is a synthetic heptapeptide derived from the human peptide tuftsin. Its amino acid sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, and research focuses primarily on the nervous system, anxiety-related mechanisms, neurotransmission, memory, and immunomodulation.

How Many Amino Acids Does Selank Contain?

Selank contains seven amino acid residues, which is why it is classified as a heptapeptide.

What Is Selank Derived From?

Selank is a synthetic analogue of tuftsin, a naturally occurring tetrapeptide with the sequence Thr-Lys-Pro-Arg. The Pro-Gly-Pro fragment is attached to this sequence.

Does Selank Affect GABA?

Preclinical findings suggest that Selank may influence the expression of genes associated with GABAergic neurotransmission. One proposed mechanism of action therefore involves allosteric modulation of the GABAergic system.

Is Selank a Benzodiazepine?

No. Selank is a peptide, whereas benzodiazepines represent a different chemical class of compounds with a different mechanism of action. However, some experimental effects of Selank are being investigated in relation to the GABAergic system, which also plays an important role in the effects of benzodiazepines.

Has Selank Been Studied in Humans?

Yes. One published study included 62 patients with generalized anxiety disorder and neurasthenia and compared Selank with medazepam. However, the overall body of clinical evidence remains limited.

Does Selank Affect Serotonin?

Experimental studies in rats have shown that Selank may alter serotonin metabolism in certain regions of the brain. However, there is insufficient evidence to simply claim that “Selank increases serotonin” in humans.

Does Selank Improve Memory?

In animal experiments, Selank was associated with increased stability of the memory trace during retention testing. However, sufficient evidence that it improves memory in healthy humans is currently lacking.

Does Selank Affect BDNF?

Preclinical studies have shown that Selank may influence BDNF expression or concentration in certain regions of the rat brain. However, these findings cannot be used to conclude that Selank has been proven to increase BDNF in humans.

Is Selank the Same as Semax?

No. Selank is derived from tuftsin, whereas Semax is based on the ACTH(4–10) fragment. They are two different peptides with distinct structures and research histories.

Conclusion: What Does Current Research Tell Us About Selank?

Selank is a synthetic heptapeptide derived from tuftsin that has become the subject of research primarily because of its potential effects on the nervous and immune systems.

Its possible interactions with the following systems have attracted the greatest scientific attention:

• the GABAergic system,
• serotonin signaling,
• enkephalins,
• learning and memory mechanisms,
• neurotrophic factors,
• cytokines and immune signaling.

Unlike many experimental peptides, Selank has also been investigated in small human studies, particularly in the areas of generalized anxiety and neurasthenia.

However, a large proportion of the mechanistic evidence still comes from animal and cellular experiments.

It is therefore most accurate to regard Selank as an interesting research peptide with neurobiological and immunomodulatory mechanisms that require further high-quality clinical investigation.

Selank from Particle Peptides

For a research peptide, quality is not defined solely by an HPLC purity percentage.

Particle Peptides emphasizes a broader system of batch-specific quality verification, transparent documentation, and independent laboratory testing.

Each batch is independently tested for:

• purity,
• identity confirmation,
• peptide content,
• endotoxin levels,
• Class 1 and Class 2 heavy metals,
• TAMC and TYMC microbial contamination.

All applicable limits comply with the standards of the European Pharmacopoeia (Ph. Eur.).

Particle Peptides bases its quality communication on laboratory data, batch-specific control, and transparency rather than solely on declared product purity.

Disclaimer: All Particle Peptides products are intended exclusively for scientific research and development purposes. They are not intended for human consumption.

References

• Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Neuroscience and Behavioral Physiology, 2008. The study included 62 patients with GAD and neurasthenia.
• Volkova A et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 2016.
• Semenova TP et al. Experimental optimization of learning and memory processes by Selank. Preclinical research into memory consolidation and serotonin metabolism.
• Kost NV et al. Semax and Selank inhibit the enkephalin-degrading enzymes of human serum. Bulletin of Experimental Biology and Medicine, 2001.
• Zozulya AA et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.
• Sokolov OY et al. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice.
• Semenova TP et al. Comparison of the effects of Selank and tuftsin on serotonin metabolism in the brain of rats.
• Inozemtseva LS et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo.
• Uchakina ON et al. Immunomodulatory effects of Selank in patients with anxiety-asthenic disorders.
• Kolomin T et al. Expression of inflammation-related genes in mouse spleen under the influence of Selank and its fragments.
• Kasian A et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology, 2017.